Article
A novel epigenetic signature for overall survival prediction in patients with breast cancer
20 Nov 2019
Abstract excerpt
BACKGROUND: Breast cancer is the most common malignancy in female patients worldwide. Because of its heterogeneity in terms of prognosis and therapeutic response, biomarkers with the potential to predict survival or assist in making treatment decisions in breast cancer patients are essential for an individualised therapy. Epigenetic alterations in the genome of the cancer cells, such as changes in DNA methylation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
